Central venous access related adverse events after trabectedin infusions in soft tissue sarcoma patients; experience and management in a nationwide multi-center study

详细信息    查看全文

• 作者：Michiel C. Verboom ; Jan Ouwerkerk ; Neeltje Steeghs…
• 关键词：Trabectedin ; Central venous catheters ; Adverse events ; Soft tissue sarcoma
• 刊名：Clinical Sarcoma Research
• 出版年：2017
• 出版时间：December 2017
• 年：2017
• 卷：7
• 期：1
• 全文大小：1055KB
• 刊物主题：Cancer Research; Oncology; Surgical Oncology;
• 出版者：BioMed Central
• ISSN：2045-3329
• 卷排序：7

文摘

BackgroundTrabectedin has shown efficacy against soft tissue sarcomas (STS) and has manageable toxicity. Trabectedin is administered through central venous access devices (VAD), such as subcutaneous ports with tunneled catheters, Hickman catheters and PICC lines. Venous access related adverse events are common, but have not yet been reported in detail.